5.67
Scisparc Ltd stock is traded at $5.67, with a volume of 28,987.
It is down -0.87% in the last 24 hours and up +1,712% over the past month.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$5.72
Open:
$5.72
24h Volume:
28,987
Relative Volume:
0.02
Market Cap:
$3.03M
Revenue:
$1.75M
Net Income/Loss:
$-5.68M
P/E Ratio:
-1.1636
EPS:
-4.8726
Net Cash Flow:
-
1W Performance:
-21.90%
1M Performance:
+1,712%
6M Performance:
+1,160%
1Y Performance:
+1,272%
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SPRC
Scisparc Ltd
|
5.67 | 3.06M | 1.75M | -5.68M | 0 | -4.8726 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd Stock (SPRC) Latest News
What are the technical indicators suggesting about SciSparc Ltd.Value Investing Entry Points With Proven Results - jammulinksnews.com
How many analysts rate SciSparc Ltd. as a “Buy”Stock Strategy Alerts For Consistent Profits - jammulinksnews.com
How volatile is SciSparc Ltd. stock compared to the marketLow Risk Report For Consistent Profits - jammulinksnews.com
How strong is SciSparc Ltd. company’s balance sheetBest Dividend Ideas For Beginners - jammulinksnews.com
What is the risk reward ratio of investing in SciSparc Ltd. stockEarnings Report Picks With High Returns - jammulinksnews.com
SciSparc Announces Patent Filing and Merger Updates - TipRanks
Why is SciSparc Ltd. stock attracting strong analyst attentionMarket Forecast Target Finder For 2025 - jammulinksnews.com
SciSparc regains compliance with Nasdaq’s listing rule - MSN
SciSparc Announces Updates Regarding Proposed Merger; Form - GlobeNewswire
SciSparc sets shareholder vote dates for AutoMax merger - Investing.com Australia
SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors - Stock Titan
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Breakthrough Patent: New Drug Combination Targets 890M Obesity Patients and Fatty Liver Disease - Stock Titan
Best data tools to analyze SciSparc Ltd. stockFree Buy Low Sell High Stock Watch - Newser
Moving Average Trends for SciSparc Ltd. Stock: What They IndicateSmart Forecast Signals from AI Models - Newser
Evaluating SciSparc Ltd. with trendline analysisFree Day Trading Signals With High Precision - Newser
Quantitative breakdown of SciSparc Ltd. recent moveFree Trade Setups With Clear Risk Limits - Newser
What moving averages say about SciSparc Ltd.Free Expert Verified Stock Trade Ideas - Newser
Does SciSparc Ltd. stock pay reliable dividendsWeekly Stock Picks with Trend Confidence - Newser
SciSparc Ltd.’s Price Action Aligns with Quant SignalsRisk Controlled Picks With Real Returns Outlined - beatles.ru
Will SciSparc Ltd. Stock Benefit from AI and Green Energy TrendsEarnings Based Stock Performance Forecast - Newser
How SciSparc Ltd. stock performs during market volatilityTrade Setup Builder with Custom Alerts - Newser
SciSparc Ltd. Could See a Relief Rally From SupportEntry Alert Based on Volume Spikes Detected - metal.it
Is SciSparc Ltd. a growth stock or a value stockPhenomenal capital gains - jammulinksnews.com
How does SciSparc Ltd. compare to its industry peersPowerful profit generation - jammulinksnews.com
What catalysts could drive SciSparc Ltd. stock higher in 2025Financial News Tips For Beginners - jammulinksnews.com
Is it the right time to buy SciSparc Ltd. stockAchieve rapid financial growth with expert help - jammulinksnews.com
What is the dividend policy of SciSparc Ltd. stockInvest smarter with expert trading signals - jammulinksnews.com
What moving averages say about SciSparc Ltd. AI Intraday Market Movement Prediction Tool - Newser
What are the latest earnings results for SciSparc Ltd.Free Stock Movement Tracking - jammulinksnews.com
Should I hold or sell SciSparc Ltd. stock in 2025Invest smarter and grow your wealth faster - jammulinksnews.com
What makes SciSparc Ltd. stock price move sharplyHigh Return Stock Alerts - metal.it
SciSparc Ltd. Earnings Report Breakdown: What Investors Should KnowChart Based Entries - Newser
Why SciSparc Ltd. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):